Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Aldosterone and Potassium in Heart Failure
Author(s): Laibah Arshad Khan , Adeena Jamil , Stephen J Greene , et al Added: 10 months ago

Heart Failure

Prevention & Chronic Conditions
Hyperkalaemia in the Cardiorenal Patient - Navigating Guidelines & Real-World Data
Author(s): Clara Bonanad Lozano , Anjay Rastogi Added: 1 year ago
Dr Anjay Rastogi (David Geffen School of Medicine UCLA, US) and Dr Clara Bonanad (University Clinical Hospital of Valencia, ES) discuss the evolving management strategies of hyperkalaemia in heart failure and chronic kidney disease, in this short video series. In this three part discussion they cover the most recent guidelines from ACC, ESC and KDIGO, real-world evidence from the recent ZORA… View more

Heart Failure

Prevention & Chronic Conditions
The Aldosterone Story: New Chapters
Author(s): Vijay Chopra Added: 3 months ago

Heart Failure
Constructing Practical Pathways for RAASi Management: A Review of Emerging Data
Author(s): Anjay Rastogi , Shelley Zieroth Added: 1 year ago
In this peer-to-peer discussion, Dr Anjay Rastogi (David Geffen School of Medicine UCLA, US) and Dr Shelley Zieroth (University of Manitoba, CA) summarise and distil emerging real-world data on modern practices and approaches to treating hyperkalaemia during RAASi therapy in cardiorenal patients to optimise RAASI therapy.Download the Free Infographic View more

Heart Failure
Mineralocorticoid Receptor Antagonists in Heart Failure
Author(s): Rishi Sethi , Pravesh Vishwakarma , Akshyaya Pradhan Added: 12 months ago

Heart Failure

MI/ACS
AHA 24 Late-Breaking Discussion: REALIZE-K
Author(s): Harriette Van Spall , Mikhail Kosiborod Added: 11 months ago
AHA Conference 2024 — REALIZE-K: Impact of sodium zirconium cyclosilicate (SZC) on HFrEF patient's potassium levels whilst on spironolactone.Late-Breaker Host, Dr Harriette Van Spall (McMaster University, CA) is joined onsite by Dr Mikhail Kosiborod (Saint Luke's Mid America Heart Institute, US) to discuss the findings from the REALIZE-K Study (NCT04676646; AstraZeneca).REALIZE-K is a phase 4… View more

Heart Failure

Prevention & Chronic Conditions
Breakthrough Mineralocorticoid Receptor Agonists in Cardiovascular Care
Author(s): Vijay Chopra , Javed Butler , Dinesh Khullar , et al Start date: Nov 17, 2025
Breakthrough Mineralocorticoid Receptor Antagonists in Cardiovascular Care brings together renowned cardiovascular experts Dr Vijay Chopra, Dr Javed Butler, Dr Dinesh Khullar, and Prof John McMurray to address critical challenges in heart failure management and hypertension treatment. This comprehensive session explores innovative approaches to mineralocorticoid receptor antagonist (MRA) therapy,… View more

Heart Failure

Prevention & Chronic Conditions
Research Area(s) / Expertise: Job title: Nephrologist
Dr Areef Ishani is a Nephrologist and Director of the Primary and Specialty Care Service Line atMinneapolis VA Health Care System, Minneapolis, MN, US. His areas of expertise are chronic kidney disease, end-stage renal disease, high potassium level, small lymphocytic lymphoma, and kidney transplant. View more
Job title: Consultant Cardiologist
Dr Henry J Dargie is Consultant Cardiologist at Western Infirmary, Glasgow, and Director of the National Advanced Heart Failure Service, Glasgow (1980-2010) Research Achievements Metolozone in renal failure and heart failure Total Body Potassium in heart and renal failure Early work on role of SNS in hypertension Early RCT work on role of captopril in HF LVH and ventricular arrhythmias… View more